Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors
BeiGene
BeiGene
Incyte Corporation
TopAlliance Biosciences
M.D. Anderson Cancer Center
Xencor, Inc.
Xencor, Inc.
Xencor, Inc.
Sun Yat-sen University
Jiangsu HengRui Medicine Co., Ltd.
Baylor College of Medicine
Xiangya Hospital of Central South University
Dana-Farber Cancer Institute
Baylor College of Medicine